Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma

被引:0
|
作者
Ren-Wen Huang
Yin-Kai Chao
Yu-Wen Wen
Hsien-Kun Chang
Chen-Kan Tseng
Sheng-Chieh Chan
Yun-Hen Liu
机构
[1] Chang Gung University,Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkou, College of Medicine
[2] Chang Gung University,Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Linkou, College of Medicine
[3] Chang Gung University,Clinical Informatics and Medical Statistics Research Center
[4] Chang Gung University,Division of Hematology/Oncology, Chang Gung Memorial Hospital, Linkou, College of Medicine
[5] Chang Gung University,Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, College of Medicine
[6] Chang Gung University,Department of Nuclear Medicine, Chang Gung Memorial Hospital, Keelung, College of Medicine
关键词
Pathological complete response; Esophageal cancer; Predictors; Neoadjuvant chemoradiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
    Habu, Takumi
    Kumanishi, Ryosuke
    Ogata, Takatsugu
    Fujisawa, Takeshi
    Mishima, Saori
    Kotani, Daisuke
    Kadowaki, Shigenori
    Nakamura, Masaki
    Hojo, Hidehiro
    Fujiwara, Hisashi
    Kumagai, Shogo
    Koyama, Shohei
    Fujita, Takeo
    Kinoshita, Takahiro
    Nishikawa, Hiroyoshi
    Yano, Tomonori
    Tajika, Masahiro
    Muro, Kei
    Mitsunaga, Shuichi
    Kojima, Takashi
    Bando, Hideaki
    ESOPHAGUS, 2023, 20 (03) : 533 - 540
  • [32] Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
    Takumi Habu
    Ryosuke Kumanishi
    Takatsugu Ogata
    Takeshi Fujisawa
    Saori Mishima
    Daisuke Kotani
    Shigenori Kadowaki
    Masaki Nakamura
    Hidehiro Hojo
    Hisashi Fujiwara
    Shogo Kumagai
    Shohei Koyama
    Takeo Fujita
    Takahiro Kinoshita
    Hiroyoshi Nishikawa
    Tomonori Yano
    Masahiro Tajika
    Kei Muro
    Shuichi Mitsunaga
    Takashi Kojima
    Hideaki Bando
    Esophagus, 2023, 20 : 533 - 540
  • [33] Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy
    Hirohata, Ryosuke
    Hamai, Yoichi
    Emi, Manabu
    Ibuki, Yuta
    Kurokawa, Tomoaki
    Ohsawa, Manato
    Kitasaki, Nao
    Okada, Morihito
    WORLD JOURNAL OF SURGERY, 2024, 48 (07) : 1700 - 1709
  • [34] Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
    Zhao, Kewei
    Wang, Chunsheng
    Shi, Fang
    Li, Minghuan
    Yu, Jinming
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (06) : 3842 - 3853
  • [35] A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
    Yang, Yu
    Yi, Yan
    Wang, Zhongtang
    Li, Shanshan
    Zhang, Bin
    Sang, Zheng
    Zhang, Lili
    Cao, Qiang
    Li, Baosheng
    BMC CANCER, 2024, 24 (01)
  • [36] CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
    Yang, Zhining
    He, Binghui
    Zhuang, Xinyu
    Gao, Xiaoying
    Wang, Dandan
    Li, Mei
    Lin, Zhixiong
    Luo, Ren
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (04) : 538 - 545
  • [37] Treatment-Related Lymphopenia Predicts Pathologic Complete Response and Recurrence in Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy
    Li, Qiaoqiao
    Zhou, Sha
    Liu, Shiliang
    Liu, Songran
    Yang, Hong
    Zhao, Lei
    Liu, Mengzhong
    Hu, Yonghong
    Xi, Mian
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2882 - 2889
  • [38] Treatment-Related Lymphopenia Predicts Pathologic Complete Response and Recurrence in Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy
    Qiaoqiao Li
    Sha Zhou
    Shiliang Liu
    Songran Liu
    Hong Yang
    Lei Zhao
    Mengzhong Liu
    Yonghong Hu
    Mian Xi
    Annals of Surgical Oncology, 2019, 26 : 2882 - 2889
  • [39] Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma
    Kawai, Takaharu
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Hagiwara, Ken
    Watanabe, Megumu
    Matsuno, Yoritaka
    Suda, Hiroshi
    Yagi, Renpei
    Takayama, Tadatoshi
    ANTICANCER RESEARCH, 2017, 37 (06) : 3301 - 3306
  • [40] Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
    Wen, Jing
    Fang, Shuogui
    Hu, Yi
    Xi, Mian
    Weng, Zelin
    Pan, Chuqing
    Luo, Kongjia
    Ling, Yihong
    Lai, Renchun
    Xie, Xiuying
    Lin, Xiaodan
    Lin, Ting
    Chen, Jiyang
    Liu, Qianwen
    Fu, Jianhua
    Yang, Hong
    EBIOMEDICINE, 2022, 86